Boehringer Ingelheim Launches PED Essentials to Strengthen Patient Voice in Healthcare Decisions — Boehringer Ingelheim International GmbH

Event summary

Boehringer Ingelheim launched PED Essentials, an online learning hub designed to help patient organizations generate and analyze high-quality patient experience data (PED).
The platform was co-created with patients and subject matter experts to address gaps in existing learning materials.
The launch coincides with growing regulatory recognition of patient experience data, including the EMA's landmark reflection paper on PED published in September 2025.
PED Essentials is freely available at www.pedessentials.com.

The big picture

The launch of PED Essentials underscores the growing importance of patient experience data in healthcare decision-making. Regulatory bodies like the EMA, FDA, NICE, and CDA-AMC are increasingly recognizing PED as a critical form of evidence, signaling a shift towards more patient-centric healthcare policies and practices. Boehringer Ingelheim's initiative positions the company at the forefront of this trend, potentially influencing broader industry standards and practices.

What we're watching

Regulatory Alignment: How the EMA's final guidance on PED will impact the adoption and implementation of patient experience data in regulatory decision-making.
Patient Advocacy: Whether patient organizations can effectively leverage PED Essentials to strengthen their advocacy efforts and influence healthcare policies.
Industry Adoption: The pace at which other pharmaceutical companies and healthcare stakeholders will integrate patient experience data into their evidence-based strategies.